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an important role in the molecular organization of syn-
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Summary The specificity of binding of NR2 and Shaker-type
subunits to different members of the PSD-95 family ap-
Chapsyn-110, a novel membrane-associated puta- pears to be indistinguishable by in vitro binding and
tive guanylate kinase (MAGUK) that binds directly to yeast two-hybrid assays (Kim et al., 1995; Niethammer
N-methyl-D-aspartate (NMDA) receptor and Shaker K1 et al., 1996), but the in vivo specificity of interactions
channel subunits, is 70%–80% identical to, and shares between these groups of proteins is unknown. This is
an identical domain organization with, PSD-95/SAP90 an especially significant question since the two charac-
and SAP97. In rat brain, chapsyn-110 protein shows terized members of the PSD-95 family, PSD-95 (also
a somatodendritic expression pattern that overlaps known as SAP90) and SAP97 (also known as hdlg), show
partly with PSD-95 but that contrasts with the axonal rather contrasting subcellular distributions in neurons.
distribution of SAP97. Chapsyn-110 associates tightly PSD-95 has been localized to both presynaptic and
with the postsynaptic density in brain, and mediates postsynaptic locations (Cho et al., 1992; Kistner et al.,
the clustering of both NMDA receptors and K1 chan- 1993; Hunt et al., 1996), whereas SAP97 is concentrated
nels in heterologous cells. Indeed, chapsyn-110 and in axons and axon terminals (Mu¨ller et al., 1995). Shaker-
PSD-95 can heteromultimerize with each other and type K1 channels are found predominantly in presynap-
are recruited into the same NMDA receptor and K1 tic terminals and on axons in rat brain, and a subset
channel clusters. Thus, chapsyn-110 and PSD-95 may including Kv1.1 and Kv1.2 are clustered in the juxtapara-
interact at postsynaptic sites to form a multimeric nodal regions of the nodes of Ranvier (Sheng et al.,
scaffold for the clustering of receptors, ion channels, 1992, 1993, 1994b; Wang et al., 1993, 1994; Maletic-
and associated signalling proteins.
Savatic et al., 1995; Rhodes et al., 1995). In contrast,
NMDA receptors are concentrated at postsynaptic sites,
though a significant fraction appears to be presynaptic
Introduction (Aoki et al., 1994; Liu et al., 1994; Petralia et al., 1994;
Siegel et al., 1994). Although examples of colocalization
The proper distribution of voltage-gated and ligand- of PSD-95 with Shaker-type K1 channels have been de-
gated ion channels on the neuronal surface is critical scribed in brain (Kim et al., 1995), and with NMDA recep-
for the processing and transmission of electrical signals tors in cultured neurons (Kornau et al., 1995), the protein
in neurons. Different classes of these ion channels are
expression patterns of PSD-95 and SAP97 in the brain
targeted to and largely immobilized at specific sites on
do not overlap completely with the distribution of NMDA
the neuronal membrane. The molecular mechanisms
receptors and Shaker subfamily K1 channels, suggest-that mediate the sorting, clustering, and anchoring of
ing the existence of additional members of the MAGUKchannel proteins is largely unknown, especially in the
family that might associate with K1 channels and NMDAcentral nervous system (Froehner et al., 1993).
receptors in the CNS.Recently, the PSD-95/SAP90 subfamily of membrane-
Recently, by use of the yeast two-hybrid system, weassociated putative guanylate kinases (abbreviated
have identified a third and novel member of the PSD-MAGUKs) has been shown to bind directly to Shaker-
95 subfamily of MAGUKs that binds to the C-terminustype K1 channel and N-methyl-D-aspartate (NMDA) re-
of Shaker K1 channel subunits (Kim et al., 1995), as wellceptor 2 (NR2) subunits (Kim et al., 1995; Kornau et al.,
as to NR2 subunits (Niethammer et al., 1996). We report1995; Niethammer et al., 1996). Binding occurs directly
the cloning and characterization of this protein, whichbetween the conserved short peptide motif (-ET/SXV) at
we call chapsyn (channel-associated protein of syn-the C-terminus of the cytoplasmic tails of these subunits
apses)-110, and compare its distribution and clusteringand the N-terminal two PDZ domains of PSD-95. In the
behavior with its two known relatives, PSD-95 andcase of Shaker-subtype voltage-gated K1 channels, this
SAP97. The chapsyn-110 protein is 70%–80% identicalinteraction results in the coclustering of both channel
to PSD-95 and SAP97 at the amino acid level, and showsand PSD-95 proteins in cotransfected cells (Kim et al.,
an identical domain organization, with three PDZ do-1995). Clustering of NMDA receptors has not yet been
demonstrated in heterologous cells, but examples of mains in the N-terminal half, a guanylate kinase (GK)
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Figure 1. Structure of Chapsyn-110 Protein
(A) Comparison of the structure and domain
organization of chapsyn-110, SAP97, and
PSD-95 in schematic form (drawn to scale).
White boxes indicate positions at which dif-
ferent sequence insertions are found, pre-
sumably resulting from alternative splicing.
The extent of the fusion proteins used for
immunization, and for affinity purification of
chapsyn-110 antibodies, is indicated (for de-
tails, see Results and Experimental Proce-
dures).
(B) Amino acid sequence alignment of chap-
syn-110 (ratand human), PSD-95,and SAP97.
Residues conserved in at least three of these
sequences are shown against a black back-
ground, while conservative changes are
shaded gray. The boundaries of the PDZ,
SH3, and GK domains are indicated, as are
the extents of the Chapsyn-S23 and Chap-
syn-INS fusion proteins used for affinity puri-
fication of chapsyn-specific antibodies (see
Experimental Procedures). Shown at the in-
sertion site (INS) between the SH3 and GK
domains are two different sequences for the
rat and human genes. Either insertion 1
(shown in the human chapsyn-110 sequence)
or insertion 2 (shown in the rat sequence) can
be found at this site in chapsyn-110 cDNAs.
The rat chapsyn-110 sequence is 97% identi-
cal to another rat sequence deposited in Gen-
Bank (accession number U50717) termed
PSD-93 (Brenman et al., 1996).
homology region of unknown function near the C-termi- 110 kD) (see below), by analogy to 43K/rapsyn, the ace-
nus, and an intervening SH3 domain. Of particular inter- tylcholine receptor clustering molecule of neuromuscu-
est, we show that chapsyn-110 can form heteromulti- lar junctions (Apel and Merlie, 1995). The rat gene for
mers with PSD-95, and that both these proteins can chapsyn-110 was independently isolated by low strin-
cluster NMDA receptor subunits, as well as Shaker type gency screening of a rat cDNA library using PSD-95,
K1 channels in heterologous cells. and is z97% identical to the human homolog at the
amino acid level (Figure 1).
The amino acid sequence of chapsyn-110 is mostResults
divergent from PSD-95 and SAP97 in three different
regions of the protein: the N-terminal region before thePrimary Structure of Chapsyn-110
first PDZ domain (PDZ1); the region between PDZ2 andA fragment of a novel member of the PSD-95 family
PDZ3; and the segment between the SH3 and guanylate(termed “clone 5” in Kim et al., [1995]) was originally
kinase domains. In this inter-SH3/GK region we haveisolated in a yeast two-hybrid screen of a human brain
found evidence of two alternative insertions (of lengthcDNA library, using Kv1.4 C-terminal tail as bait. Clone
33 and 15 amino acids) occurring after residue 626 of5 was used to isolate further overlapping cDNAs by
chapsyn-110, presumably reflecting differential exonhybridization screening of human brain cDNA libraries.
splicing at this site. Interestingly, hdlg/SAP97 also ex-The deduced sequence of the full-length cDNA open
hibits alternative exon usage (Lue et al., 1994) in thereading frame predicts a protein of 870 amino acids and
same region between its SH3 and GK domains.a molecular weight of z95 kD (Figure 1), which is closely
Northern analysis revealed that chapsyn-110 mRNArelated to SAP97 (78% identity, 89% similarity), PSD-95
is expressed predominantly in neural tissues (Figure 2).(71% identity, 85% similarity), and the Drosophila discs
There were two transcripts (major band z6.0 kb, minorlarge protein (57% identity, 72% similarity). We termed
this novel protein chapsyn-110 (apparent molecular size band z5.0 kb) expressed in brain, and to a lesser extent,
Channel Clustering by Heteromeric Chapsyn-110/PSD-95
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Figure 2. Northern Blot Analysis of Chapsyn-110 mRNA Expression
in Multiple Rat Tissues
10 mg of total RNA from the indicated tissues were probed with
chapsyn-110 cDNA at high stringency. DRG: dorsal root ganglia;
SCG: superior cervical ganglion, SiN: sciatic nerve.
in superior cervical ganglion. Chapsyn-110 mRNA was
not detected inheart, skeletal muscle, kidney, lung, liver,
or spleen, but a faint signal was observed in the adrenal
gland.
Specificity of Chapsyn-110, PSD-95,
Figure 3. Expression of Chapsyn-110 Protein in Rat Brain
and SAP97 Antibodies
(A) Immunoblot analysis of specificity of chapsyn-110, PSD-95, andTo investigate chapsyn-110 expression at the protein
SAP97 antibodies and differential regional expression of these pro-
level, chapsyn-110-specific antibodies were generated. teins in rat brain. Whole cell extracts of untransfected COS-7 cells,
Rabbit antisera were raised against a bacterial fusion and of cells transfected with PSD-95, SAP97, or chapsyn-110
cDNAs, were separated on a 6% polyacrylamide/SDS gel along withprotein incorporating chapsyn-110 residues 343–660,
membrane fractions (10 mg protein) from different regions of brainwhich begins in the middle of the region between PDZ2
or liver, as indicated. Filters were probed with Chapsyn-S23, PSD-and PDZ3, and that extends to include insertion 1 lo-
95, and SAP97 antibodies, as indicated. Positions of molecular size
cated between SH3 and GK domains (Figure 1). To de- markers are shown in kD. Abbreviations: Untrans. (untransfected),
rive antibodies specific for chapsyn-110, which do not Ctx (cortex), Hpc (hippocampus), Cbl (cerebellum), Subcx (subcorti-
cross-react with other PSD-95 family members, these cal regions).
(B) Differential subcellular fractionation of chapsyn-110, PSD-95,antisera were then affinity purified, using a fusion protein
and SAP97. Lanes were loaded with rat brain fractions, as follows:encompassing residues 343–417 (termed Chapsyn-S23)
whole br (total brain homogenate, 20 mg protein), soluble (S100corresponding to the highly divergent spacer region be-
supernatant fraction of brain homogenate, 30 mg), memb (crude
tween PDZ2 and PDZ3 and a fusion protein incorpo- synaptosomal membrane fraction, 10 mg and 2 mg); PSDI, PSDII,
rating residues 627–660 (termed Chapsyn-INS), corre- PSDIII (purified PSD fractions after extraction with Triton X-100 once
sponding to the unique insertion between SH3 and GK (I), twice (II), or with Triton X-100 followed by sarkosyl (III)). Filters
were probed with Chapsyn-S23, Chapsyn-INS, PSD-95, and SAP97domains (insertion 1, Figure 1B). Chapsyn-S23 antibod-
antibodies, as indicated. Different quantities of protein were loadedies should recognize all forms of chapsyn-110, whereas
into the lanes: to show relative fractionation, equal percentagesChapsyn-INS antibodies would be expected to recog-
(rather than equal mass) of membrane and soluble fractions were
nize the subset of chapsyn-110, which contains insertion loaded; the soluble fraction contained three times higher concentra-
1. The majority of the chapsyn-110 cDNAs we have iso- tion of total protein than the membrane fraction. To show purification
lated contain the insertion 1 sequence. into the PSD fractions, only 2 mg of PSDI, PSDII, and 1 mg of PSDIII
were immunoblotted, and compared with 2 mg of membrane frac-Chapsyn-S23 antibodies specifically recognize a dif-
tion. Due to nonlinearity of the chemiluminescent reaction and offuse band of Mr z110 kD in immunoblots of chapsyn-
the photographic process, the weak chapsyn-110 signal in 2 mg of110-transfectedCOS-7 cells, butdo not cross-react with
crude synaptosomal membranes became almost invisible.
SAP97 or PSD-95-transfected cells by immunoblotting
(Figure 3A), or by immunocytochemistry (data not
shown). By similar analysis, the PSD-95 and SAP97 anti- Differential Regional Expression and Subcellular
Fractionation of Chapsyn-110 in Rat Brainbodies recognize their respective antigens, but show no
cross-reactivitywith the other twomembers of the family On immunoblots of rat brain membranes, Chapsyn-S23
antibodies specifically recognize a heterogeneous bandby immunoblotting or immunostaining of transfected
COS-7 cells (Figure 3A; data not shown). of z110 kD that comigrates with the band found in
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Figure 4. Differential Immunohistochemical
Lobcalization of Chapsyn-110 in Rat Brain
(A–D) Immuno-staining of cerebellar cortex
showing contrasting patterns of immunore-
activity for chapsyn-110 (A and D), SAP97 (B),
and PSD-95 (C). Note the similar somatoden-
dritic staining of Purkinje cells with two differ-
ent antibodies to chapsyn-110: Chapsyn-S23
(A) and Chapsyn-INS (D). Abbreviations: M,
molecular layer; P, Purkinjecell layer; G, gran-
ule cell layer; W, white matter.
(E–G) Somatodendritic localization of chap-
syn-110, as detected by Chapsyn-S23 anti-
bodies, in neurons of cerebral cortex layer 5
(E), pyramidal neurons of area CA3 (F) and of
area CA1 (G) of hippocampus. Abbreviations:
P, pyramidal cell layer; Sr, stratum radia-
tum. Scale bar represents 200 mm (A–D), 100
mm (E–G).
COS-7 cells transfected with chapsyn-110 cDNA (Figure Immunohistochemical Distribution of
Chapsyn-110 Protein in Rat Brain3A).Chapsyn-110 protein is abundant inmembrane frac-
tions from cerebral cortex, hippocampus, and subcorti- Affinity purified Chapsyn-S23 and Chapsyn-INS anti-
bodies were used to localize chapsyn-110 protein incal regions, but is present at lower levels in cerebellum.
A similar size band and expression pattern was seen rat brain sections. Chapsyn-S23 immunostaining was
consistently stronger, though the patterns of immuno-using the chapsyn-INS antibodies (data not shown). The
regional expression pattern of chapsyn-110 is some- reactivity were similar with both antibodies (Figure 4A
and 4D).what similar to PSD-95, but markedly different from
SAP97, which is most abundant in cerebellum and at Chapsyn-110 protein is widely expressed in neurons
throughout the brain, but at particularly high levels inrelatively low levels in hippocampus and subcortical re-
gions (Figure 3A). cortex, hippocampus, and basal ganglia. At the subcel-
lular level, chapsyn-110 immunoreactivity was distrib-Like PSD-95 and SAP97, chapsyn-110 is associated
with the crude synaptosomal membrane fraction from uted consistently in a somatodendritic pattern, with light
staining of the cell bodies and prominent staining ofrat brain (Figure 3B). A significant proportion of all three,
however, is found in the soluble fraction, which is partic- dendrites and surrounding neuropil, clearly seen in cor-
tex and hippocampus (Figures 4E, 4F, and 4G). Theularly enriched for the lower molecular weight compo-
nents of the chapsyn-110 and PSD-95 immunoreactive somatodendritic staining pattern of chapsyn-110 in hip-
pocampal pyramidal neurons is similar to that reportedbands (Figure 3B). These apparently lower molecular
weight soluble species may represent immaturely pro- for PSD-95 (Cho et al., 1992).
The immunostaining pattern of chapsyn-110 is dis-cessed forms of chapsyn-110 and PSD-95. Since none
of these proteins contain predicted transmembrane do- tinct, however, from that of PSD-95 or SAP97. The dif-
ferential distribution of chapsyn-110 with respect tomains, they are presumably peripheral membrane pro-
teins. Membrane-associated chapsyn-110 further puri- PSD-95 and SAP97 is most clearly seen in the cerebel-
lum, where chapsyn-110 immunoreactivity is promi-fies into the postsynaptic density fraction where it is
resistant to both Triton X-100 and sarkosyl detergent nently found in the soma and dendritic trees of Purkinje
cells (Figure 4A). In contrast, SAP97 immunostaining isextraction (Figure 3B). In this respect, its behavior re-
sembles that of PSD-95 (Figure 3B; Cho et al., 1992) strongest in the neuropil of the molecular layer, and the
Purkinje cell bodies and dendrites stand out in relief asand contrasts with that of SAP97. SAP97 is associated
with synaptosomal membranes but does not copurify unstained elements (Figure 4B). This cerebellar SAP97
staining pattern is in agreement with Mu¨ller et al. (1995)with PSD-95 or chapsyn-110 into postsynaptic density
fractions (Figure 3B); this finding is consistent with who showed SAP97 to be concentrated in parallel fiber
axons. PSD-95 immunoreactivity shows a third distinctSAP97 being predominantly an axonal and nerve termi-
nal protein (Mu¨ller et al., 1995). pattern, being particularly highly concentrated in the
Channel Clustering by Heteromeric Chapsyn-110/PSD-95
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Figure 5. K1 Channel Clustering Activity of
Chapsyn-110
COS-7 cells were transfected with cDNAs en-
coding the proteins listed at the bottom left
of each panel. When multiple proteins are
coexpressed, the name of the protein that is
visualized by the primary antibody is indi-
cated in color (red or green indicates that the
secondary antibody was labeled with Cy3 or
FITC, respectively). (A), (B), and (C) indicate
different cells visualized, whileF1 and F2 indi-
cate the same cell visualized through differ-
ent immunofluorescence channels. When in-
dividually expressed in COS-7 cells, Kv1.4 (A),
chapsyn-110 (B), and myc-tagged chapsyn-
110 (C) are diffusely distributed in the cell.
Coexpression of chapsyn-110 results in the
clustering of Kv1.4 (D), but not of a Kv1.4
mutant in which the C-terminal sequence has
been changed from -ETDV to -ETDA (E). Co-
expression of Kv1.4 and myc-tagged chap-
syn-110 results in the coclustering of both
proteins, as visualized by double immuno-
fluorescence in the same cell by Kv1.4 anti-
bodies (F1, red), and 9E10 anti-myc mouse
monoclonal antibody (F2, green). Since the
anti-myc signal (green) was lower than the
Kv1.4 signal (red), the photographic process
resulted in the false impression that the myc-
chapsyn-110 clusters are smaller than the
Kv1.4 clusters. When viewed directly, these
two proteins are exactly colocalized. In cells coexpressing chapsyn-110 and PSD-95, both chapsyn-110 (G1, red) and PSD-95 (G2, green)
show indistinguishable diffuse distributions throughout the cell. In cells triply transfected with Kv1.4 1 chapsyn-110 1 PSD-95, typical clusters
form in which chapsyn-110 (H1, red) and PSD-95 (H2, green) are exactly colocalized by double immunofluorescence. Abbreviations: Chap
(chapsyn-110); Chap-myc (myc epitope-tagged chapsyn-110); Kv1.4 mut (Kv1.4 -ETDA C-terminal mutant).
basket cell nerve terminal plexuses wrapped around the as with wild-type chapsyn-110, but by using mouse
monoclonal antibodies (9E10) recognizing the myc-axon hillocks of Purkinje neurons (Figure 4C). Taken
together with immunoblotting data, these results indi- epitope, we could demonstrate that in coexpressing
cells, chapsyn-110 coclustered with Kv1.4 in the samecate that chapsyn-110, PSD-95, and SAP97 proteins
show distinctive (though in the case of chapsyn-110 plaques at the cell surface (Figure 5F). The size, shape,
and texture of chapsyn-110/Kv1.4 coclusters is veryand PSD-95, overlapping) patterns of expression at the
regional, cellular, and subcellular levels in rat brain. similar to those seen with PSD-95/Kv1.4 (Kim et al.,
1995; data not shown). Thus, chapsyn-110 behaves like
PSD-95 not only in its ability to bind Shaker subfamilyChapsyn-110 Is a K1 Channel
Clustering Molecule and NR2 subunits (Kim et al., 1995; Niethammer et al.,
1996), but also in its ability to cocluster with Shaker K1To test whether chapsyn-110 can function like PSD-95
in ion channel clustering (Kim et al., 1995), chapsyn-110 channels.
was cotransfected into COS-7 cellswith theShaker-type
K1 channel subunit Kv1.4. Expressed by itself, chapsyn- Chapsyn-110 Is Recruited into the Same K1
Channel Clusters as PSD-95110 immunoreactivity is diffusely distributed in COS
cells (Figure 5B); Kv1.4 by itself shows a diffuse surface COS cells doubly transfected with chapsyn-110 and
PSD-95 show a diffuse intracellular immunoreactivity fordistribution and an intracellular immunoreactivity pat-
tern suggestive of accumulation in the endoplasmic re- both proteins, similar to the pattern seen with either
protein alone (Figure 5G). Thus, these two MAGUKs doticulum, in agreement with previous studies (Figure 5A;
Kim et al., 1995). When cotransfected in the same cells, not induce each other to aggregate or cluster when
coexpressed. In triple (Kv1.4 1 PSD-95 1 chapsyn-110)however, chapsyn-110 results in the dramatic surface
clustering of Kv1.4 (Figure 5D), but not of a Kv1.4 mutant transfected cells, however, typical surface clusters were
formed in which both PSD-95 and chapsyn-110 werein which the C-terminal binding motif had been mutated
from -ETDV to -ETDA (Figure 5E). Coclustering of the exactly colocalized (Figure 5H). In parallel experiments,
these chapsyn-110/PSD-95 containing clusters werechapsyn-110 and wild-type Kv1.4 could not be directly
shown by double immunofluorescence because anti- shown to colocalize with Kv1.4 immunoreactivity (data
not shown). These results imply that Kv1.4 recruits bothbodies to both proteins were derived from rabbits.
Therefore, a myc epitope-tagged version of chapsyn- chapsyn-110 and PSD-95 into the same membrane-as-
sociated complexes, at least at the light microscopic110 was constructed. Cotransfection experiments with
chapsyn-110-myc produced Kv1.4 -channel clustering level.
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Figure 6. NMDA Receptor Clustering Activity
of Chapsyn-110 and PSD-95
Panels are labeled using the same scheme
as in Figure 5. When individually expressed
in COS-7 cells, NR2A (A) and NR2B (B) are
distributed in a perinuclear and cytoplasmic
reticular pattern. Cotransfection of chapsyn-
110 and NR2A results in redistribution of both
chapsyn-110 (C) and NR2A (D) into plaque-
like clusters. Similarly, coexpression of NR2B
and PSD-95 results in clusters in which NR2B
and PSD-95 can be directly colocalized in the
same cell (E1, E2). Chapsyn-110 and PSD-95
behaved identically with respect to clustering
of either NR2A or NR2B (data not shown).
Cells triply transfected with NR2B 1 chap-
syn-110 1 PSD-95 form typical clusters in
which chapsyn-110 and PSD-95 are exactly
colocalized by double immunofluorescence
(F1, F2). In cells doubly transfected with NR1
and chapsyn-110 (G1, G2), or NR1 and PSD-
95 (H1, H2), both proteins are diffusely distrib-
uted with no evidence of colocalization. How-
ever, in cells triply transfected with NR1 1
NR2A or NR2B 1 chapsyn-110 or PSD-95,
NR1 colocalizes in clusters with chapsyn-110
(I) and PSD-95 (J). The NR2B antibodies gave
some background nuclear staining. Abbrevi-
ations: NR1 (NR1A splice variant; Sugihara et
al., 1992).
Clustering of NMDA Receptors et al., 1992; Monyer et al., 1992). In contrast with NR2,
we find that expression of the NR1 subunit (the commonby Chapsyn-110 and PSD-95
Although PSD-95 and its relatives also bind specifically splice variant NR1A) with either chapsyn-110 or PSD-
95 does not result in cocluster formation (Figures 6G andto the C-terminal tails of NR2 subunits, clustering of
NMDA receptors by these proteins has not been pre- 6H). Instead, both proteins remain diffusely distributed
in the same cell as if each was individually expressed,viously shown. When NR2Aor NR2B is transfected alone
into COS-7 cells, the expressed protein is distributed in consistent with this NR1 subunit not having the C-termi-
nal binding motif for PDZ domains. Significantly, how-a perinuclear and a cytoplasmic reticular pattern (Fig-
ures 6A and 6B) not dissimilar from that of Kv1.4 (Figure ever, in triple transfections with NR1 1 NR2A/NR2B 1
chapsyn-110/PSD-95, NR1 did cocluster with chapsyn-5A). Cotransfection with chapsyn-110 or PSD-95, how-
ever, results in the formation of plaque-like clusters of 110 and PSD-95 (Figure 6I and 6J). The requirement for
NR2 subunit coexpression in NR1 clustering implies thatNR2A (Figure 6D) and NR2B (Figure 6E1), in which PSD-
95 can be shown to be colocalized (Figure 6E2). The NR1/NR2 heteromeric NMDA receptors were formed
that then clustered via the binding of chapsyn-110 andappearance of these coclusters is essentially indistin-
guishable from that of Kv1.4 clusters, although the effi- PSD-95 to the NR2 subunits. Taken together, these re-
sults demonstrate that chapsyn-110 and PSD-95 canciency of NR2 clustering (z10%–20% of cotransfected
cells show convincing cluster formation) is lower than cluster heteromeric NMDA receptors, as well as NR2
subunits.that of Kv1.4 clustering (z40%–70%), possibly due to
the weaker expression level of NR2 proteins. In triple
transfections of NR2 1 chapsyn-110 1 PSD-95, typical Chapsyn-110 Heteromultimerizes
with PSD-95 but Not SAP97plaque-like clusters were formed in which chapsyn-110
and PSD-95 exactly colocalize (Figures 6F1 and F2); The coclustering of chapsyn-110 and PSD-95 in the
presence of Kv1.4 or NR2 subunits could reflect recruit-thus NR2A and NR2B behave like Kv1.4 in being able
to recruit both chapsyn-110 and PSD-95 into the same ment of chapsyn-110 and PSD-95 monomers, chapsyn-
110, and PSD-95 homomultimers, or chapsyn-110/PSD-clusters. Identical results were obtained with either
NR2A or NR2B in these clustering experiments, so only 95 heteromultimers, into the clusters. To test whether
chapsyn-110 and PSD-95 can form heteromeric com-representative results are shown. For either K1 channel
or NMDA receptor subunits, we found no significant plexes, these two proteinswere expressed togetherwith
SAP97 in COS-7 cells in the absence of channel sub-difference in the relative clustering efficiencies of the
homomeric chapsyn-110 or PSD-95 versus the hetero- units, and their association was assayed by coimmuno-
precipitation. Control experiments indicated that chap-meric PSD-95/chapsyn configurations.
Formation of fully functional NMDA receptors requires syn-S23 and SAP97 antibodies are highly specific for
their respective antigens in immunoprecipitation fromthe NR1 subunit, in addition to NR2 subunits (Meguro
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antibodies showed slight cross-reactivity for chapsyn-
110 in immunoprecipitation (Figure 7A), and were there-
fore not used as immunoprecipitating antibodies in
these experiments.
The coimmunoprecipitation of PSD-95 using chap-
syn-S23 antibodies is extremely unlikely to represent
cross-reactivity of these antibodies for PSD-95 because
chapsyn-S23 antibodies are directed against a unique
region in chapsyn-110 (Figure 1B); chapsyn-S23 anti-
bodies do not cross-react with PSD-95 or SAP97 on
Western blots (Figure 3A) or by immunoprecipitation
from singly transfected COS-7 cells (Figure 7A); and
coimmunoprecipitation of PSD-95by Chapsyn-S23 anti-
bodies was abolished by denaturation of COS cell ex-
tracts in boiling SDS, while immunoprecipitation of
chapsyn-110 was little affected (Figure 7B), suggesting
that PSD-95 and chapsyn-110 associate through nonco-
valent SDS-sensitive bonds. These coimmunoprecipita-
tion results indicate that chapsyn-110 and PSD-95 form
heteromeric complexes even in the absence of Kv1.4,
and when both proteins are diffusely distributed in the
cell (Figure 5G).
Not surprisingly, when cells are quadruply transfected
with Kv1.4 plus the three MAGUKs, chapsyn-110 and
PSD-95 remain coimmunoprecipitable with each other,
but in addition, Kv1.4 is now coimmunoprecipitated with
either chapsyn-110 or PSD-95 (data not shown). These
results confirm that the coclustering of all three proteins
seen in these cells is based on a complex formed be-
tween K1 channel subunits and chapsyn-110 and
PSD-95.Figure 7. Coimmunoprecipitation of Chapsyn-110 and PSD-95
(A) Specificity of chapsyn-110 and SAP97 antibodies in immunopre-
Discussioncipitation. COS-7 cells were separately transfected with chapsyn-
110, SAP97, or PSD-95 cDNAs, and equal amounts of each cell
lysate were immunoprecipitated (“IP”) with Chapsyn-S23, SAP97 or Chapsyn, a Novel Member of the PSD-95 Family
PSD-95 antibodies, as indicated. The immunoprecipitates were then of Ion Channel Clustering Proteins
immunoblotted for chapsyn-110, SAP97, and PSD-95, as shown. Chapsyn-110, a third and new member of the PSD-95
Chapsyn-S23 and SAP97 antibodies are highly specific for their
subfamily of MAGUKs, is 70%–80% identical to PSD-cognate antigens, whereas PSD-95 antibodies shows slight cross-
95 and SAP97, and approximately as different from PSD-reactivity to chapsyn-110, in this immunoprecipitation assay. Thus,
95 and SAP97 as the latter are different from each other.only Chapsyn-S23 and SAP97 antibodies were used as immuno-
precipitating antibodies in part B. The domain organization is identical in this family, with
(B) Coimmunoprecipitation of chapsyn-110 and PSD-95. Extracts the major differences in primary structure occurring out-
from COS-7 cells triply transfected with chapsyn-110 1 PSD-95 1 side the highly conserved PDZ, SH3, and GK domains.
SAP97, were immunoprecipitated with Chapsyn-S23, SAP97 or neg-
This close sequence homology is reflected by someative control Kv1.4 antibodies, as indicated. Immunoprecipitates
functional similarities of these proteins. Like its twowere then immunoblotted for PSD-95, chapsyn-110, or SAP97, as
known relatives, chapsyn-110 binds to the C-terminalindicated at the right of each panel. The first lane (“lysate”) was
loaded directly with the transfected cell lysate. In “boil and IP” tails of Shaker K1 channel and NR2 subunits through its
controls, extracts were first denatured in boiling SDS before immu- highly conserved PDZ1 and PDZ2 domains (Kim et al.,
noprecipitation with the indicated antibodies. 1995; Niethammer et al., 1996). Furthermore, in heterolo-
gous cells, chapsyn-110 coexpression results in coclus-
tering with Shaker-type K1 channels and NR2 subunits
singly transfected COS-7 cell extracts (Figure 7A). How- at the cell surface, similar to the coclustering seen with
ever, from detergent extracts of triply (PSD-95 1 chap- PSD-95 (Kim et al., 1995). Thus, with respect to primary
syn-110 1 SAP97) transfected cells, chapsyn-S23 anti- structure, in vitro protein-protein interactions, and chan-
bodies consistently immunoprecipitated large amounts nel clustering activity in heterologous cells, chapsyn-
of PSD-95 in addition to chapsyn-110 (Figure 7B). Inter- 110 is homologous to other members of the PSD-95
estingly, there was no detectable coimmunoprecipita- family. Thus, chapsyn-110 joins an emerging set of pro-
tion of SAP97 with chapsyn-110 antibodies, and only teins that are likely to be important, not only in the
weak coimmunoprecipitation of PSD-95 with SAP97 an- clustering and anchoring of ion channels and receptors,
tibodies (Figure 7B), suggesting that chapsyn-110 and but also in the coupling of receptors/ion channels to
PSD-95 associate preferentially with each other rather intracellular signalling pathways, perhaps by acting as
than with SAP97. Negative control Kv1.4 antibodies did scaffolds for a submembrane signalling complex (Bren-
man et al., 1996). However, an important question isnot immunoprecipitate any of these proteins. PSD-95
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raised by the multiplicity of genes in this family: do these there is substantial overlap in their distribution in rat
brain, these results suggest that chapsyn-110 and PSD-highly related proteins have different functions in vivo?
95 may cooperate at common postsynapticsites to clus-
ter ion channels and their associated intracellular signal-Differential Subcellular Localization
ing proteins.of Chapsyn-110
A clue to potential differences in function is provided
by the differential localization of chapsyn-110 and its NMDA Receptor-Clustering by Chapsyn-110
and PSD-95relatives in vivo. Chapsyn-110, PSD-95, and SAP97 are
widely expressed in distinct though overlapping pat- NR2 subunits share the C-terminal ES/TXV motif with
Shaker subunits, but are otherwise totally dissmilar fromterns in rat brain. At the subcellular level, chapsyn-110
distribution shows much in common with that of PSD-95 their K1 channel counterparts. Therefore, successful
clustering of NR2 proteins by chapsyn-110 and PSD-95but is insharp contrast with SAP97. The somatodendritic
localization of chapsyn-110 in cortical and hippocampal (Figure 6) reinforces the idea that binding of the
C-terminal tail of these membrane proteins is crucial inpyramidal neurons, for instance, is similar to that de-
scribed for PSD-95 (Cho et al., 1992; Hunt et al., 1996), the mechanism of clustering. Together with colocaliza-
tion data (Kornau et al., 1995), our results indicate thatand both these proteins copurify with each other in
detergent-extracted postsynaptic density fractions. an interaction between NR2 subunitsand chapsyn/PSD-
95 in the postsynaptic density may underlie the cluster-Clearly, however, some fraction of PSD-95 is also found
in axon terminals of inhibitory neurons (Kistner et al., ing of NMDA receptors at postsynaptic sites. Moreover,
since NR2 subunits bind to either PDZ1 or PDZ2 of1993; Kim et al., 1995). Thus, PSD-95 can be considered
“mixed” pre- and postsynaptic. Chapsyn-110appears to chapsyn-110 and PSD-95 (Kornau et al., 1995; Nietham-
mer et al., 1996) and neuronal nitric oxidesynthase bindsbe a predominantly postsynaptic member of this family;
whether some fraction is located presynaptically will to PDZ2 (Brenman et al., 1996), the clustering activity
of chapsyn-110 and PSD-95 should result in the coag-require immunoelectronmicroscopic resolution. SAP97,
in contrast, is targeted to axons and excitatory presyn- gregation of NMDA receptors with a downstream signal-
ing protein (nNOS) that is regulated by NMDA receptoraptic terminals (Mu¨ller et al., 1995), a conclusion that
is supported by our independent immunohistochemical activation. Furthermore, our demonstration of NMDA
receptor clustering now make it possible to test whetherdata (Figure 4 and E. K. and M. S., unpublished data).
Consistent with SAP97 being segregated to the axonal/ PSD-95 family proteins can organize heterogeneous ion
channel clusters in which K1 channels and NMDA recep-terminal pole of neurons, our biochemical studies reveal
SAP97 to be unique among this family in not being asso- tors are intimately mixed, as might be the case in vivo.
The important finding that NR1/NR2 complexes areciated with the postsynaptic density. In conclusion, al-
though theexpression pattern of chapsyn-110 is distinct coclustered with either chapsyn-110 or PSD-95 implies
that the PSD-95 family can cluster heteromeric iono-from the other two members of the family, its postsynap-
tic distribution overlaps with PSD-95 most closely. tropic receptors as well as homotetrameric ion channels
like Kv1.4 K1 channels. The subunit stoichiometry of
NMDA receptors is still unresolved, so it is currentlyFunctional Similarities between Chapsyn-110
unclear how many ES/TXV-containing subunits perand PSD-95
channel are required for clustering by the PSD-95 familyIn addition to similarities in subcellular localization,
of proteins. The simplest cross-linking model (Gom-chapsyn-110 shows functional activities that resemble
perts, 1996; see below) requires at least two C-terminalPSD-95 rather than SAP97. Although all three of these
ES/TXV binding motifs per channel complex, and thisMAGUKs have indistinguishable binding specficities for
criterion is likely to be fulfilled in heteromeric NMDAK1 channels and NMDA receptors in vitro and in the
receptors. Since NR2 subunits by themselves are clus-yeast two-hybrid system, only chapsyn-110 and PSD-
tered by chapsyn-110 and PSD-95, this model raises95 form coclusters efficiently at the cell surface with
the intriguing possibility that NR2 subunits might formchannel subunits. SAP97 does interact with Kv1.4 when
homo-oligomers, even though these are not functionalcoexpressed in COS-7 cells, but the two proteins form
as NMDA receptors.large intracellular coaggregates (E. K. and M. S., unpub-
lished data) rather than the flat coclusters seen at the
cell surface with chapsyn-110 or PSD-95. The reason Heteromultimerization of Chapsyn-110 and
Mechanisms of Ion Channel Clusteringfor this different clustering behavior is unknown. SAP97
may have distinct molecular requirements for surface The finding that chapsyn-110 and PSD-95 are associ-
ated in a heteromeric complex in the absence of Kv1.4clustering that are not present in COS-7 cells, and that
may reflect the specialization of SAP97 for an axonal or NR2 subunits indicates that PSD-95 family proteins
can exist as multimers even prior tococlustering with ionfunction.
Perhaps the most compelling sign that chapsyn-110 channels. The stoichiometry of multimerization, whether
individual members of the PSD-95 family also formand PSD-95 are more closely related functionally is that
they form heteromultimers with each other but not with homo-multimers, and whether they bind directly to each
other or via some endogenously expressed linker pro-SAP97, and are recruited into the same clusters when
coexpressed with K1 channel or NMDA receptor pro- tein, are important questions that remain to be an-
swered. In view of the similarities in subcellular distribu-teins. Furthermore, they both interact with neuronal ni-
tric oxide synthase (Brenman et al., 1996). Given that tion and clustering activity shared by chapsyn-110 and
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fragment from one of the positives was subcloned in Bluescript KS-PSD-95, it may be especially significant that these two
plasmid and used to screen 300,000 plaques from the same librarymembers of the family associate much more efficiently
at high stringency (Church and Gilbert, 1984). We identified andwith each other than with SAP97. The data raise the
analyzed six positives further, and used two cDNA clones to gener-
possibility that PSD-95 and chapsyn-110 are closely ate the 3 kb cDNA, which contains the whole coding region.
interacting at postsynaptic sites in vivo. An analogous
heteromeric association is known to exist for two tight Northern Analysis
Total RNA was isolated from various tissues as described by Chom-junction proteins of the MAGUK superfamily, ZO-1 and
czynski and Sacchi (1987). 10 mg of total RNA was separated onZO-2, which can be coimmunoprecipitated from epithe-
1.5% agarose formaldehyde gels, transferred to Hybond nylon mem-lial cells (Gumbiner et al., 1991; Jesaitis and Good-
brane (Amersham), and UV-crosslinked. A 1.6 kb PCR product (nu-
enough, 1994). cleotide 800–2,400) was amplified using the rat chapsyn-110 cDNA
Previous models of K1 channel clustering by mono- as template, and then used to generate random primed radiolabeled
meric PSD-95 depended on the presence of two PDZ probe.
domains per PSD-95 molecule that can bind channel
Antibodiessubunits. In these cross-linking models, tetrameric K1
Anti-chapsyn-110 antisera were raised by immunizing rabbits withchannels containing four C-terminal tails could be cross-
a hexahistidine-tagged fusion protein incorporating residues 343–linked into raft-like clusters in the membrane by the
660 of human chapsyn-110 (Figure 1A, diagram). This segment of
divalent binding sites on each PSD-95 molecule (Kim et the chapsyn-110 cDNA was amplified by PCR and subcloned in
al., 1995; for review, see Gomperts, 1996). The discovery frame in the pRSETB vector (Invitrogen). The resulting bacterial
of PSD-95/chapsyn-110 multimerization offers novel in- fusion protein was purified to homogeneity by Nickel-NTA affinity
chromatography. To obtain chapsyn-110-specific antibodies thatsight into the mechanism of ion channel clustering be-
did not cross-react with PSD-95 or SAP97, the antisera were affinitycause it obviates the requirement for multiple channel
purified using two thioredoxin fusion proteins encoding unique seg-binding sites per PSD-95 monomer. Instead, a single
ments of chapsyn-110 (see Figure 1B); Chapsyn-S23 (incorporating
binding site (such as one of the PDZ domains) on each residues 343–417), and Chapsyn-INS (incorporating residues 627–
MAGUK molecule can contribute to channel cross-link- 660). Plasmid constructs were prepared by PCR amplification of the
ing by being part of a multivalent multimeric complex. desired cDNA segment and subcloning into pET TRX (thioredoxin)
fusion systemvector 32 (Novagen), which also includes a hexahistid-The ability of these MAGUKs to associate with them-
ine segment, thus allowing purification of the resulting fusion pro-selves or with each other implies a stoichiometric multi-
teins by Ni-NTA affinity chromatography. Purified Chapsyn-S23 andplication of the number of PDZ domains in each com-
Chapsyn-INS fusion proteins were coupled to separate columns
plex. Since PDZ domains are directly responsible for (Sulfolink, Pierce) for affinity purification of the respective anti-
the binding of membrane ion channels, the multimeriza- bodies.
tion of chapsyn-110 and PSD-95 at specific membrane SAP97 antisera were generated by immunizing rabbits with a GST
fusion protein (constructed in pGEX4T-1, Pharmacia) incorporatingsites can increase the local concentration of channel
residues 1–105 of rat SAP97, a unique region of the SAP97 proteinbinding sites and enhance the ability of these proteins
(see Figure 1). Antibodies were then affinity purified using a purifiedto mediate the clustering of receptors and ion channels,
thioredoxin fusion of the same SAP97 segment (constructed in pET
especially at the high densities found in synapses (Hall TRX 32, Novagen), coupled to Sulfolink columns (Pierce).
and Sanes, 1993). Intriguingly, if the different members PSD-95-specific antibodies used in immunohistochemistry, im-
of the PSD-95 family were to have distinct channel bind- munofluorescence, and immunoprecipitation were generated in
guinea pig, and have been described in Kim et al., 1995. For PSD-ing specificities in vivo, heteromerization between them
95 immunoblotting, we used affinity purified rabbit anti-peptide anti-would increase the variety of ion channels in a cluster.
bodies raised against the synthetic peptide CSKRRVERREWSRLKAIndeed, we have recently isolated a novel protein that
KDWG, corresponding to amino acids 490–508 of PSD-95. The
interacts relatively specifically with chapsyn-110 (M. S., N-terminal cysteine residue was added for coupling purposes.
unpublished data), consistent with the idea that hetero- Anti-NR1 mouse monoclonal antibody was purchased from Phar-
multimerizationof chapsyn-110 and PSD-95 could regu- mingen. NR2A or NR2B antibodies have been described in Sheng
et al., 1994a.late the heterogeneity and composition of membrane
protein clusters. In these heterogeneous clusters, the
Immunoblotting, Immunohistochemistry,stoichiometric ratio of different classes of ion channel
and Immunoprecipitationcould be altered simply by regulating the degree of het-
Cell lysates from transfected COS-7 cells were prepared by Dounce
eromerization between chapsyn-110, PSD-95, and their homogenization in phosphate buffered saline (PBS) containing pro-
relatives. tease inhibitors. Crude synaptosomal membrane fractions from rat
brain (Sheng et al., 1992), and detergent-extracted postsynaptic
density (PSD) fractions (Cho et al., 1992) were prepared as previouslyExperimental Procedures
described. Immunoblotting with enhanced chemiluminescence re-
agents (ECL, Amersham) was performed as described (Sheng et al.,Chapsyn-110 cDNA Cloning
The original human chapsyn-110 cDNA fragment was isolated in a 1993, 1994b), except that semi-dry electrophoretic transfer of the
proteins to nitrocellulose was used. Affinity purified antibodies wereyeast two-hybrid screen using Kv1.4 as bait (“clone 5” in Kim et al.,
1995). The clone 5 fragment was used as a hybridization probe used at z1 mg/ml concentration.
Immunohistochemistry was performed on Vibratome-cut 50 mmto obtain from a human lambda gt11 human brain cDNA library
(Clontech) further cDNAs that encompassed residues 117–870 of floating brain sections from Sprague Dawley rats (z6 weeks age)
perfused transcardiacally with 4% paraformaldehyde, and perme-human chapsyn-110 . Clones containing sequences upstream of
amino acid 117 were obtained by 59 RACE using “Marathon”-ready abilized with either 0.3% Triton X-100 or 50% ethanol, as described
in Sheng et al. (1994b), and Liu et al. (1994). Affinity purified antibod-human brain cDNA (Clontech).
The rat chapsyn-110 cDNA was isolated after screening a rat ies were used at 0.5–1 mg/ml, final concentration.
Coimmunoprecipitation was performed as described in Sheng etbrain cDNA lambda gt11 library (Clontech) with radiolabeled PSD-
95 cDNA (Cho et al., 1992). z300,000 plaques were screened at low al. (1994a). Dounce homogenized lysates from transfected COS-7
cells were extracted in 50-fold volume of Tris-buffered saline (TBS,stringency conditions (Church and Gilbert, 1984). A 1.6 kb EcoRI
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pH 7.4) containing 1% NP-40, 0.5% deoxycholate, 0.1% SDS at 48C Gomperts, S.N. (1996). Clustering membrane proteins: it’sall coming
together with the PSD-95/SAP90 protein family. Cell 84, 659–662.for 1 hr. After centrifugation at 16,000g for 30 min, the supernatant
was incubated with affinity- purified primary antibody (2 mg/ml) at Gumbiner, B., Lowenkopf, T., and Apatira, D. (1991). Identification
48C for 1 hr. Immunoprecipitates were collected with protein of a 160 kDa polypeptide that binds to the tight junction protein
A-sepharose, separated in a 6% SDS PAGE gel and analyzed by ZO-1. Proc. Natl. Acad. Sci. USA 88, 3460–3464.
immunoblotting.
Hall, Z., and Sanes, J.R. (1993). Synaptic structure and development:
the neuromuscular junction. Neuron 10,99–122.DNA Constructions
Hunt, C.A., Schenker, L.J., and Kennedy, M.B. (1996). PSD-95 isFor expression in COS-7 cells, Kv1.4, PSD-95, SAP97, chapsyn-
associated with the postsynaptic density and not with the presynap-110, NR1 (Moriyoshi et al., 1991), NR2A and NR2B (Ishii et al., 1993;
tic membrane at forebrain synapses. J. Neurosci. 16, 1380–1388.Monyer et al., 1992) cDNAs were subcloned in the mammalian ex-
pressionvector GW1-CMV (British Biotechnology). The -ETDA muta- Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H.,
tion of the C-terminus of Kv1.4 was generated by PCR amplification Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., Masu, M., and
of the entire Kv1.4 coding region, using mutant 39 primer that substi- Nakanishi S. (1993). Molecular characterization of the family of the
tuted A for V at the C-terminal residue. The resulting product was N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268, 2836–
subcloned into GW1-CMV expression vector, like the wild-type 2843.
Kv1.4. For myc-tagging of chapsyn-110, an AscI site was introduced Jesaitis, L.A., and Goodenough, D.A. (1994). Molecular characteriza-
between amino acid 14 and 15 in the chapsyn-110 cDNA by inverse tion and tissue distribution of ZO-2, a tight junction protein homolo-
PCR, and a cassette encoding the myc epitotpe (EQKLISEEDL) was gous to ZO-1 and the Drosophila discs large tumor suppressor
inserted into the AscI site. Constructs were verified by nucleotide protein. J. Cell Biol. 124,949–961.
sequencing.
Kim, E., Niethammer, M., Rothschild, A., Jan, Y.N., and Sheng, M.
(1995). Clustering of Shaker-type K1 channels by interaction withCell Transfection and Coclustering Assay
a family of membrane-associated guanylate kinases. Nature 378,COS-7 cells were transfected at z40%–60% confluence, using the
85–88.Lipofectamine method (GIBCO-BRL), either on poly-lysine coated
microwell slides or coverslips (for coclustering experiments) or in Kistner, U., Wenzel, B.M., Veh, R.W., Cases-Langhoff, C., Garner,
100 mm tissue culture dishes (for preparation of extracts for immu- A. M., Appeltauer, U., Voss, B., Gundelfinger, E.D., and Garner, C.C.
noblotting and immunoprecipitation). For transfection of NR1 and (1993). SAP90, a rat presynaptic protein related to the product of
NR2A/NR2B subunits, a DNA mass ratio of 1:8 was used. Cells the Drosophila tumor suppressor gene dlg-A. J. Biol. Chem. 268,
transfected with NMDA receptor subunits were incubated in a me- 4580–4583.
dium containing 0.5 mM ketamine. To assay clustering, cells were Kornau, H.-C., Schenker, L.T., Kennedy, M.B., and Seeburg, P.H.
fixed 2 days after transfection in 2% paraformaldehyde, permeabil- (1995). Domain interaction between NMDA receptor subunits and
ized with 0.1% Triton X-100, and stained with primary antibodies at the postsynaptic density protein PSD-95. Science 269, 1737–1740.
1 mg/ml concentration, and with Cy3- or FITC- labeled secondary
Lahey, T., Gorczyca, M., Jia, X.-X., and Budnik, V. (1994). The Dro-antibodies (Jackson Immunoresearch) at dilutions of 1:1000 and
sophila tumor suppressor gene dlg is required for normal synaptic1:200, respectively. Immunofluorescence was viewed with a Zeiss
bouton structure. Neuron 13, 823–835.Axioskop microscope.
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